Clinical Trials in Minneapolis

Showing 9781-9800 of 14,456 trials

Vidaza to Restore Hormone Thx Prostate

NCT00384839

The purpose of this research study is to find out what effects (good and bad) Vidaza has on patients with prostate cancer. This investigational drug is not approved by the Food and Drug Administration (FDA) for the treatment of prostate cancer; however, it is approved in myelodysplastic syndrome - a bone marrow disease. The pharmaceutical company involved in this study, Pharmion Corporation, is the manufacturer of Vidaza.

Prostate Cancer

US Oncology Research36 participantsStarted Apr 2006

Denver, Colorado, United States • Ocoee, Florida, United States • Minneapolis, Minnesota, United States +10 more locations

COMPLETEDPhase 2< 1 mile

BKM120 for Patients With PI3K-activated Tumors

NCT01833169

The purpose of this signal seeking study was is to determine whether treatment with BKM120 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study.

PI3K Pathway Activated Tumors

Novartis Pharmaceuticals146 participantsStarted Mar 2013

Phoenix, Arizona, United States • Sedona, Arizona, United States • Fayetteville, Arkansas, United States +56 more locations

Vidaza to Restore Hormone Thx Prostate

BKM120 for Patients With PI3K-activated Tumors

Find Trials by Condition in Minneapolis

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

A Study in Subjects With Moderate Atopic Dermatitis

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Long-term Open-Label Safety Study to Evaluate EN3409

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety